# Role of Inflammasomes in COVID-19 Disease

> **NCT04385017** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 99 (actual)

## Conditions studied

- COVID-19 by SARS-CoV-2 Infection

## Interventions

- **OTHER:** COVID-19 patients

## Key facts

- **NCT ID:** NCT04385017
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-11
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04385017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04385017, "Role of Inflammasomes in COVID-19 Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04385017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*